Periodontal Disease and Salivary Mitofusin Levels
Evaluation of the Roles of Salivary Mitofusin-1 and Mitofusin-2 Levels in Periodontal Disease
1 other identifier
observational
81
0 countries
N/A
Brief Summary
The aim of this observational study is to find out whether there is a level difference in salivary mitofusin-1 and mitofusin-2 levels due to changes in periodontal status. The main question it aims to answer is:
- Do salivary mitofusin-1 and mitofusin-2 levels of periodontitis patients differ from healthy patients?
- Could salivary mitofusin-1 and mitofusin-2 levels be biomarkers for periodontal disease? Biochemical analysis will be performed on saliva samples taken at once from gingivitis or periodontitis patients and healthy individuals who apply to the periodontology clinic, at the initial stage of the treatment. There is no ongoing monitoring or second sampling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2024
CompletedFirst Posted
Study publicly available on registry
July 19, 2024
CompletedStudy Start
First participant enrolled
July 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2024
CompletedJuly 19, 2024
July 1, 2024
1 month
July 5, 2024
July 14, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Mitofusin-1 concentration
Mitofusin-1 concentration in saliva, determined as a result of biochemical analysis
Up to four weeks from start of work
Mitofusin-2 concentration
Mitofusin-2 concentration in saliva, determined as a result of biochemical analysis
Up to four weeks from start of work
IL-1B concentration
IL-1B concentration in saliva, determined as a result of biochemical analysis
Up to four weeks from start of work
Study Arms (3)
Healthy
Gingivitis
Periodontitis
Interventions
It is the examination of saliva samples taken with biochemical methods. In this way, the substances in its content and the concentration of cytokines are analyzed.
Eligibility Criteria
Patients with gingivitis and periodontitis presenting to the periodontology clinic, as well as healthy individuals
You may qualify if:
- Being between the ages of 18 and 65.
- Willing to participate in the study and provide a saliva sample.
- Having a healthy periodontal condition, gingivitis, or periodontitis (Stage 3-4, Grade C).
- Having fasted from any food or drink (except water) for the past 2 hours prior to providing the saliva sample.
- Having refrained from brushing teeth or using mouthwash in the past 2 hours prior to providing the saliva sample.
- Not having any systemic diseases.
- Not currently taking any medications regularly.
You may not qualify if:
- Having used antibiotics within the last 6 months.
- Having received periodontal treatment within the last 6 months.
- Having fewer than 20 teeth (excluding third molars).
- Having any systemic diseases.
- Not smoking or having quit at least 5 years ago.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Okumus OF, Kurt N, Kantarci A. Salivary mitofusin levels in periodontal disease: a cross-sectional case-control study. BMC Oral Health. 2025 Oct 6;25(1):1542. doi: 10.1186/s12903-025-06932-0.
PMID: 41053720DERIVED
Biospecimen
human saliva samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 5, 2024
First Posted
July 19, 2024
Study Start
July 25, 2024
Primary Completion
August 25, 2024
Study Completion
September 25, 2024
Last Updated
July 19, 2024
Record last verified: 2024-07